Dendreon Pharmaceuticals
As of the edition of 20 October 2026, Dendreon Pharmaceuticals runs 1 drug, 1 of them marketed.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Family history
Dendreon Pharmaceuticals was bankrupt in 2015.
- Dendreon Pharmaceuticals LLC: bankrupt in 2015
Drugs by status
| Status | Count |
|---|---|
| Marketed | 1 |
| Total | 1 |
Marketed drugs and when their US protection ends
| Drug | US protection | Route B rows |
|---|---|---|
| SIPULEUCEL-T | Ended 2022 (computed from the first US licence) | 0 |
A route B row is one company at one target.